Navigation Links
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer

PITTSBURGH, Oct. 1 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced the appointment of Brian Byala as Senior Vice President and Treasurer, effective October 22, 2007. Mr. Byala joins Mylan from Pfizer Inc. where he was Assistant Treasurer with responsibility for treasury planning in both New York and Dublin. Mr. Byala spent more than 10 years at Pfizer in various treasury positions of increasing responsibility. Prior to Pfizer, Mr. Byala was employed by Grant Thornton in Durban, South Africa.

Mr. Byala has extensive experience with the management of both short- and long-term debt issuance, financial asset investment, stock repurchase programs, foreign exchange risk, FAS 133 hedge accounting, capital structure analysis and daily treasury operations. His responsibilities have also included Sarbanes-Oxley compliance and serving as the treasury lead during large scale corporate integrations.

Mylan Vice Chairman and CEO Robert J. Coury commented: "As we expand our footprint and operations around the world, it is more important than ever that we maintain an optimal capital structure that balances Mylan's strategic goals, shareholder value creation, and dynamic market conditions. Brian's extensive knowledge and experience managing capital structures of large multi- national companies will ensure that we maintain a best-in-class treasury function at Mylan that meets the needs of our evolving business. As I've stated many times, we are clearly focused on building up our management team with the best and brightest talent in the industry. I'm very pleased to welcome Brian to the Mylan family."

Mr. Byala earned an MBA from the Johnson Graduate School of Management at Cornell University, a graduate diploma in taxation and a bachelor's of commerce (honors) from the University of Natal-Durban in South Africa.

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. For more information about Mylan, please visit .

SOURCE Mylan Laboratories Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional ... models of traditional and far-infrared saunas. , For traditional saunas, Finnleo is ... traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic White Spruce ...
(Date:11/25/2015)... ... 26, 2015 , ... Ministers, senior government and UN agencies, ... Centres of Excellence, and public R&D institutions, civil societies and other partners gathered ... 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a Jacksonville-based drug ... their sobriety and show through pictures what a positive difference it makes. The ... with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short ...
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm of ... decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and ... Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified that ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015 Allergan plc (NYSE: ... Rugen Therapeutics, a start-up  biotechnology company focused on ... disorders and funded by the F-Prime Biomedical Research ... into an exclusive collaboration to support the discovery ... Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 USP 800 applies to all ... pharmacists, pharmacy technicians, nurses, physicians, physician assistants, home ... also covers all entities which store, prepare, transport, ... healthcare institutions, patient treatment clinics, physicians, practice facilities, ... --> What is the purpose of ...
(Date:11/25/2015)... 2015 Asia -based ... BioLight and the New Investors will make a direct ... a private placement. The financing will help IOPtima to ... used in the treatment of glaucoma, as well as ... IOPtimate™ system with the U.S. Food and Drug Administration, ...
Breaking Medicine Technology: